Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population

scientific article published in March 2004

Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.20048
P698PubMed publication ID15022339
P5875ResearchGate publication ID5309181

P50authorArja HäkkinenQ40606601
P2093author name stringTuulikki Sokka
Eswar Krishnan
Pekka Hannonen
Helen Hubert
P2860cites workMajor public health benefits of physical activityQ35063984
Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patientsQ38482066
Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations.Q52072835
The effect of cigarette smoking on musculoskeletal-related disabilityQ23909897
Smoking-gender interaction and risk for rheumatoid arthritisQ24804476
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001Q29614193
Aging, health risks, and cumulative disabilityQ34463316
P433issue3
P921main subjectdisabilityQ12131
questionnaireQ747810
P304page(s)953-960
P577publication date2004-03-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleNormative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population
P478volume50

Reverse relations

cites work (P2860)
Q36675274A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors
Q86846347A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the h
Q36366162ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis
Q48076353Acceptability of less than perfect health states in rheumatoid arthritis: the patients' perspective
Q24241707Anakinra for rheumatoid arthritis
Q24243387Anakinra for rheumatoid arthritis
Q24657922Assessment of the age-specific disability weight of chronic schistosomiasis japonica
Q99564907Association of age with the non-achievement of clinical and functional remission in rheumatoid arthritis
Q34456168Associations between multiple accelerometry-assessed physical activity parameters and selected health outcomes in elderly people--results from the KORA-age study
Q37224059Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C.
Q51180314Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades.
Q38182440Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach
Q51906908Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial.
Q48022172Course and prognostic factors of disability in community-dwelling older people with mild disability: the Rotterdam Study
Q38860583Degenerative Spondylolisthesis is Related to Multiparity and Hysterectomies in Older Women
Q33456162Development and assessment of floor and ceiling items for the PROMIS physical function item bank
Q37329497Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis.
Q89459292Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice
Q37089877Differences in presentation of younger and older systemic sclerosis patients in clinical trials
Q48507695Different ethnic background is associated with distinct clinical profiles in the spondyloarthritides in the North and South of Brazil
Q53506587Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.
Q34587206Distribution and determinants of functioning and disability in aged adults--results from the German KORA-Age study
Q50155002Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database
Q91612432Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs
Q37210207Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
Q36083931Establishing a Common Metric for Physical Function: Linking the HAQ-DI and SF-36 PF Subscale to PROMIS(®) Physical Function
Q41685488Evaluation of functional capacity in individuals with signs and symptoms of musculoskeletal disease: results of the BRAZCO population study (Brazilian COPCORD Study).
Q33577299Extending the floor and the ceiling for assessment of physical function
Q41544298Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal study
Q34361748Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study
Q39173670Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
Q48151392Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register
Q37075921Health status of individuals with serious mental illness
Q37689724Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study
Q59790838Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
Q51201512Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
Q44403988Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Q35106951Late-age onset systemic sclerosis.
Q50114940Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies
Q37172675Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
Q38010363Measures of adult general functional status: SF-36 Physical Functioning Subscale (PF-10), Health Assessment Questionnaire (HAQ), Modified Health Assessment Questionnaire (MHAQ), Katz Index of Independence in activities of daily living, Functional In
Q38010372Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos
Q35636564Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis
Q36001105Musculoskeletal Pain, Self-reported Physical Function, and Quality of Life in the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Cohort
Q34205061Normative values for the Bath Ankylosing Spondylitis Functional Index in the general population compared with ankylosing spondylitis patients in Morocco.
Q48372838Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
Q35636868Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial
Q41595008Patient's perspective of sustained remission in rheumatoid arthritis
Q41704162Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment
Q24798309Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI)
Q45111901Population-based normative values for the Western Ontario and McMaster (WOMAC) osteoarthritis index and the Australian/Canadian (AUSCAN) hand osteoarthritis index functional subscales
Q44719067Predictors of Recovery After Conservative Treatment of AO-Type A Thoracolumbar Spine Fractures Without Neurological Deficit
Q35743200Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus
Q36780940Quantitative measures to assess patients with rheumatic diseases: 2006 update
Q40977464Sample Size Requirements for Traditional and Regression-Based Norms
Q38848721Sarcopenia is associated with disability status-results from the KORA-Age study.
Q35313168Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: a systematic review
Q35496180Self-reported disability in adults with severe obesity.
Q42273153Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
Q37308290The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration
Q37119095The impact of arthritis on the physical function of a rural Maya-Yucateco community and factors associated with its prevalence: a cross sectional, community-based study
Q59411299The importance of disability as a health issue for mid-life women
Q35163376The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice
Q61797049Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs
Q39815843Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.
Q40235244Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
Q40676684Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology.
Q91797957Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT
Q47360442Validation and reliability of the Timed Up and Go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional study.
Q34221999Valuation of scleroderma and psoriatic arthritis health states by the general public
Q35842618Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters
Q37207061Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study

Search more.